4DMedical Limited (ASX:4DX), a leader in respiratory imaging technology, has announced a milestone agreement with Qscan Radiology Clinics. Following the success of a pilot program, this commercial contract marks the first in Australia to incorporate products from 4DMedical’s Pulmonary Function and Pulmonary Structure suites, including the innovative CT LVAS™.
Key Highlights
- Pilot Success: A pilot program demonstrated the clinical and operational value of 4DMedical’s proprietary imaging solutions.
- Commercial Agreement: Qscan will offer 4DMedical’s respiratory imaging technology at select Brisbane practices, supporting advanced diagnostics and improved lung health outcomes.
- Comprehensive Product Offering: The agreement includes solutions such as CT LVAS™, Lung Density Analysis™ – Inspiration (LDAi), Functional Lung Density Analysis™ (LDAf), and Lung Texture Analysis™ (LTA).
Expanding Lung Health Diagnostics in Australia
Qscan Radiology Clinics, with 40 locations across Queensland, New South Wales, ACT, Tasmania, and Western Australia, is one of Australia’s leading providers of diagnostic imaging services. Through this partnership, clinicians and patients in Brisbane will gain access to 4DMedical’s cutting-edge respiratory imaging technology, enhancing diagnostic capabilities for lung health conditions.
The reports will be delivered via a Software-as-a-Service (SaaS) model, consistent with 4DMedical’s agreements with other commercial partners, ensuring scalability and cost-effectiveness.
Leadership Insights
Andreas Fouras, 4DMedical’s MD/CEO and Founder, stated:
“This partnership ensures more patients and clinicians can access detailed, actionable insights into lung health, supporting better healthcare outcomes. With the addition of Qscan to our network of providers in Australia, our footprint continues to grow, making our cutting-edge technology more readily available to all Australians.”
A Growing Commercial Momentum
The agreement with Qscan builds on 4DMedical’s ongoing success in commercialising its technology across the US and Australia. By incorporating both Pulmonary Function and Pulmonary Structure suites, the partnership exemplifies the Company’s commitment to delivering advanced diagnostic tools that transform lung health assessments.
4DMedical is poised to expand its presence in the Australian market, ensuring broader access to its innovative imaging solutions while supporting improved healthcare outcomes for patients nationwide.
